申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:EP2189449A1
公开(公告)日:2010-05-26
Disclosed is a compound represented by the formula (1) below or a pharmaceutically acceptable salt thereof, which is useful as an agent for prevention and/or treatment of diabetes and the like.
(In the formula, RA and RB independently represent an optionally substituted alkyl group or the like; RC represents an optionally substituted alkyl group or the like; RD represents a hydrogen atom or the like; RE represents a hydrogen atom or the like; and RF represents a group selected from those represented by the formulae (G1) below:
wherein one hydrogen atom serves as a bonding hand, or the like.)
本发明公开了由下式(1)代表的化合物或其药学上可接受的盐,可用作预防和/或治疗糖尿病等的药物。
(在式中,RA 和 RB 分别代表任选取代的烷基或类似物;RC 代表任选取代的烷基或类似物;RD 代表氢原子或类似物;RE 代表氢原子或类似物;RF 代表选自下式 (G1) 所代表的基团:
其中一个氢原子作为键手等)。